
Valerie Lynn Woodward
Examiner (ID: 335, Phone: (571)270-1479 , Office: P/3771 )
| Most Active Art Unit | 3771 |
| Art Unit(s) | 3771, 3785 |
| Total Applications | 995 |
| Issued Applications | 694 |
| Pending Applications | 59 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8416607
[patent_doc_number] => 20120244107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'BIODEGRADABLE HYDROGEL'
[patent_app_type] => utility
[patent_app_number] => 13/502397
[patent_app_country] => US
[patent_app_date] => 2010-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7916
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502397
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502397 | BIODEGRADABLE HYDROGEL | Oct 6, 2010 | Abandoned |
Array
(
[id] => 8126675
[patent_doc_number] => 20120087887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'Composition and Method for Arresting Blood Flow and for Forming a Persistent Microbial Barrier'
[patent_app_type] => utility
[patent_app_number] => 12/900170
[patent_app_country] => US
[patent_app_date] => 2010-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3977
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20120087887.pdf
[firstpage_image] =>[orig_patent_app_number] => 12900170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/900170 | Composition and Method for Arresting Blood Flow and for Forming a Persistent Microbial Barrier | Oct 6, 2010 | Abandoned |
Array
(
[id] => 8094213
[patent_doc_number] => 20120082719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'Compositions For Treating Chronic Viral Infections'
[patent_app_type] => utility
[patent_app_number] => 12/898074
[patent_app_country] => US
[patent_app_date] => 2010-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6903
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20120082719.pdf
[firstpage_image] =>[orig_patent_app_number] => 12898074
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/898074 | Compositions For Treating Chronic Viral Infections | Oct 4, 2010 | Abandoned |
Array
(
[id] => 8393232
[patent_doc_number] => 20120231076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING RIVAROXABAN'
[patent_app_type] => utility
[patent_app_number] => 13/499347
[patent_app_country] => US
[patent_app_date] => 2010-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9960
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499347
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499347 | PHARMACEUTICAL COMPOSITIONS COMPRISING RIVAROXABAN | Oct 4, 2010 | Abandoned |
Array
(
[id] => 9015622
[patent_doc_number] => 20130230586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'Treatment of Tinnitus and Related Auditory Dysfunctions'
[patent_app_type] => utility
[patent_app_number] => 13/877370
[patent_app_country] => US
[patent_app_date] => 2010-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6871
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877370 | Treatment of Tinnitus and Related Auditory Dysfunctions | Oct 1, 2010 | Abandoned |
Array
(
[id] => 6148830
[patent_doc_number] => 20110020425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Materials and methods for wound treament'
[patent_app_type] => utility
[patent_app_number] => 12/924547
[patent_app_country] => US
[patent_app_date] => 2010-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8155
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020425.pdf
[firstpage_image] =>[orig_patent_app_number] => 12924547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/924547 | Materials and methods for wound treament | Sep 28, 2010 | Abandoned |
Array
(
[id] => 8453773
[patent_doc_number] => 20120264719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR'
[patent_app_type] => utility
[patent_app_number] => 13/497349
[patent_app_country] => US
[patent_app_date] => 2010-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11913
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497349
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497349 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR | Sep 19, 2010 | Abandoned |
Array
(
[id] => 9003137
[patent_doc_number] => 20130224262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'TRANSDERMAL PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 13/820704
[patent_app_country] => US
[patent_app_date] => 2010-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3099
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820704
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/820704 | TRANSDERMAL PREPARATION | Sep 15, 2010 | Abandoned |
Array
(
[id] => 8300928
[patent_doc_number] => 20120183487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'Novel Composition for Treating External Injuries and Eschars'
[patent_app_type] => utility
[patent_app_number] => 13/496757
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2241
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496757
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/496757 | Novel Composition for Treating External Injuries and Eschars | Sep 14, 2010 | Abandoned |
Array
(
[id] => 6097435
[patent_doc_number] => 20110003745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'GRANULATE-MATRIX'
[patent_app_type] => utility
[patent_app_number] => 12/881464
[patent_app_country] => US
[patent_app_date] => 2010-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6676
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003745.pdf
[firstpage_image] =>[orig_patent_app_number] => 12881464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/881464 | GRANULATE-MATRIX | Sep 13, 2010 | Abandoned |
Array
(
[id] => 8251996
[patent_doc_number] => 20120156311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'COMBINATION THERAPY FOR CANCER COMPRISING A PLATINUM-BASED ANTINEOPLASTIC AGENT AND A BIOCOMPATIBLE ELECTRON DONOR'
[patent_app_type] => utility
[patent_app_number] => 13/393284
[patent_app_country] => US
[patent_app_date] => 2010-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19292
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156311.pdf
[firstpage_image] =>[orig_patent_app_number] => 13393284
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393284 | COMBINATION THERAPY FOR CANCER COMPRISING A PLATINUM-BASED ANTINEOPLASTIC AGENT AND A BIOCOMPATIBLE ELECTRON DONOR | Aug 31, 2010 | Abandoned |
Array
(
[id] => 8251983
[patent_doc_number] => 20120156312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'Compositions for Inhibiting Growth of Cancer Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 13/393290
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4944
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156312.pdf
[firstpage_image] =>[orig_patent_app_number] => 13393290
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393290 | Compositions for Inhibiting Growth of Cancer Stem Cells | Aug 29, 2010 | Abandoned |
Array
(
[id] => 6024171
[patent_doc_number] => 20110052497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Minimally Invasive Systems and Methods for In Vivo Testing of Materials'
[patent_app_type] => utility
[patent_app_number] => 12/870261
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8321
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12870261
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/870261 | Minimally Invasive Systems and Methods for In Vivo Testing of Materials | Aug 26, 2010 | Abandoned |
Array
(
[id] => 8264803
[patent_doc_number] => 20120164231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates'
[patent_app_type] => utility
[patent_app_number] => 13/322757
[patent_app_country] => US
[patent_app_date] => 2010-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10413
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322757
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/322757 | Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates | Aug 23, 2010 | Abandoned |
Array
(
[id] => 6381024
[patent_doc_number] => 20100316734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'METHODS OF THERMOGRAPH-GUIDED MEDICAL TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/862663
[patent_app_country] => US
[patent_app_date] => 2010-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3679
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0316/20100316734.pdf
[firstpage_image] =>[orig_patent_app_number] => 12862663
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/862663 | METHODS OF THERMOGRAPH-GUIDED MEDICAL TREATMENT | Aug 23, 2010 | Abandoned |
Array
(
[id] => 6070239
[patent_doc_number] => 20110045089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'VITAMIN K3 DERIVATIVE / NSA FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/850220
[patent_app_country] => US
[patent_app_date] => 2010-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2432
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12850220
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/850220 | VITAMIN K3 DERIVATIVE / NSA FORMULATION | Aug 3, 2010 | Abandoned |
Array
(
[id] => 8054239
[patent_doc_number] => 20120076848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE'
[patent_app_type] => utility
[patent_app_number] => 13/261047
[patent_app_country] => US
[patent_app_date] => 2010-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21964
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13261047
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/261047 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | Jul 20, 2010 | Abandoned |
Array
(
[id] => 6070195
[patent_doc_number] => 20110045045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Production of and uses for decellularized lung tissue'
[patent_app_type] => utility
[patent_app_number] => 12/803774
[patent_app_country] => US
[patent_app_date] => 2010-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14758
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045045.pdf
[firstpage_image] =>[orig_patent_app_number] => 12803774
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/803774 | Production of and uses for decellularized lung tissue | Jul 5, 2010 | Abandoned |
Array
(
[id] => 6602722
[patent_doc_number] => 20100323005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen'
[patent_app_type] => utility
[patent_app_number] => 12/819760
[patent_app_country] => US
[patent_app_date] => 2010-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9220
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323005.pdf
[firstpage_image] =>[orig_patent_app_number] => 12819760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/819760 | Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen | Jun 20, 2010 | Abandoned |
Array
(
[id] => 8209072
[patent_doc_number] => 20120128740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'NANOSTRUCTURED SILDENAFIL BASE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS, COMPOSITIONS OF THEM, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 13/378640
[patent_app_country] => US
[patent_app_date] => 2010-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6583
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20120128740.pdf
[firstpage_image] =>[orig_patent_app_number] => 13378640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/378640 | NANOSTRUCTURED SILDENAFIL BASE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS, COMPOSITIONS OF THEM, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Jun 17, 2010 | Abandoned |